Guangdong Shaoneng Group (000601.SZ): The company is expected to increase revenue by approximately 3.4939 million yuan in 2026 at the hydroelectric station in Hunan Province, excluding taxes.
Shao Neng Co., Ltd. (000601.SZ) announced that the "Notice of Hunan Provincial Development and Reform Commission on the Green Small Hydro Power Grid Electricity Price and Related Matters" will have an impact on the company's hydropower stations located in Hunan Province. According to preliminary estimates, under the latest electricity price policy, the company's hydropower stations in Hunan Province are expected to increase operating income by 3.4939 million yuan in 2026, and are expected to increase annual operating income by 5.2408 million yuan in 2027 and 2028.
Guangdong Shaoneng Group (000601.SZ) announced that the "Notice on the Grid Electricity Price for Green Small Hydropower and Related Matters" issued by the Hunan Provincial Development and Reform Commission will have an impact on the company's hydropower stations in Hunan Province. According to preliminary calculations, based on the latest electricity price policy, it is estimated that the company's hydropower stations in Hunan Province will increase operating income by 3.4939 million yuan in 2026, and 5.2408 million yuan annually in 2027 and 2028.
Related Articles

New stock news | Fylaland submits application to Hong Kong Stock Exchange for China's largest smart pool equipment supplier.

New stock news | Capital (601136.SH) submits a second application to the Hong Kong Stock Exchange, with total revenue exceeding 3.6 billion yuan in 2025.

Jiangsu Kanion Pharmaceutical (600557.SH) has received the approval notice for the clinical trial of Qingcan Tongluo Granules.
New stock news | Fylaland submits application to Hong Kong Stock Exchange for China's largest smart pool equipment supplier.

New stock news | Capital (601136.SH) submits a second application to the Hong Kong Stock Exchange, with total revenue exceeding 3.6 billion yuan in 2025.

Jiangsu Kanion Pharmaceutical (600557.SH) has received the approval notice for the clinical trial of Qingcan Tongluo Granules.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


